Fluid and electrolyte homeostasis in the elderly: physiological changes of ageing and clinical consequences

被引:39
作者
Miller, M [1 ]
机构
[1] SINAI HOSP BALTIMORE,DEPT MED,DIV GERIATR MED,BALTIMORE,MD
来源
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM | 1997年 / 11卷 / 02期
关键词
ageing; Alzheimer's disease; atrial natriuretic hormone; electrolytes; hypernatraemia; hyponatraemia; sodium balance; syndrome of inappropriate anti-diuretic hormone secretion; vasopressin; water balance;
D O I
10.1016/S0950-351X(97)80347-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Characteristic of the normal ageing process are changes in the renal, hormonal and thirst regulatory systems involved in the control of sodium and water balance. In the presence of disease or drug use, the ageing changes put the elderly person at increased risk of either sodium retention or loss and of water retention or loss, Clinically, these alterations in water and sodium balance are commonly expressed as either hyponatraemia or hypernatraemia with central nervous system dysfunction as the symptomatic expression. Thus, the impaired homeostasis of the many systems affecting fluid balance in the elderly is readily influenced by many of the disease states and medications which are often present in the elderly with resultant adverse clinical consequences. Awareness of these age-associated circumstances can allow the physician to anticipate the impact of illnesses and drugs and to implement a rational approach to therapeutic intervention and management.
引用
收藏
页码:367 / 387
页数:21
相关论文
共 113 条
[71]   HYPONATREMIA IN A NURSING-HOME POPULATION [J].
MILLER, M ;
MORLEY, JE ;
RUBENSTEIN, LZ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1995, 43 (12) :1410-1413
[72]   HORMONAL ASPECTS OF FLUID AND SODIUM-BALANCE IN THE ELDERLY [J].
MILLER, M .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1995, 24 (02) :233-253
[73]   DRUG-INDUCED STATES OF IMPAIRED WATER-EXCRETION [J].
MILLER, M ;
MOSES, AM .
KIDNEY INTERNATIONAL, 1976, 10 (01) :96-103
[74]  
MILLER M, 1991, REV CLIN GERONTOL, V1, P215
[75]  
MILLER M, 1985, VASOPRESSIN, P249
[76]  
MILLER PD, 1992, AM J MED, V73, P354
[77]   PATHOPHYSIOLOGIC AND PHARMACOLOGIC ALTERATIONS IN RELEASE AND ACTION OF ADH [J].
MOSES, AM ;
MILLER, M ;
STREETEN, DHP .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (06) :697-721
[78]   Secretory rhythm of vasopressin in healthy subjects with inversed sleep-wake cycle: Evidence for the existence of an intrinsic regulation [J].
Nadal, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (02) :174-176
[79]   METOCLOPRAMIDE INCREASES VASOPRESSIN SECRETION [J].
NORBIATO, G ;
BEVILACQUA, M ;
CHEBAT, E ;
BERTORA, P ;
CAVAIANI, P ;
BARUTO, C ;
FUMAGALLI, S ;
RAGGI, U .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (03) :747-750
[80]  
NUNEZ J F M, 1980, Age and Ageing, V9, P165, DOI 10.1093/ageing/9.3.165